Pyriproxyfen

All five exact presentations are currently registered in Georgia and the product line retains current UK regulatory records, exact official product information and a favourable fixed-combination assessment.

Regulatory studies and product-specific controlled or field data support adult-flea control, 12-week inhibition of flea development and labelled tick activity. Tick persistence is species-dependent and shorter in cats, while correct skin application and environmental pressure materially affect outcome.

Label-dose tolerability is generally favourable, but local reactions, transient salivation after licking and rare reversible systemic or neurologic signs can occur. Rabbits must not be treated; age, weight, illness and reproductive-use restrictions apply.

A single monthly Drop-Lock weight-band pipette is straightforward and adds long flea-life-cycle suppression, but the coat must be parted to skin, licking prevented and established household infestation managed environmentally.

All five exact presentations are currently registered in Georgia and the product line retains current UK regulatory records, exact official product information and a favourable fixed-combination assessment.

Regulatory studies and product-specific controlled or field data support adult-flea control, 12-week inhibition of flea development and labelled tick activity. Tick persistence is species-dependent and shorter in cats, while correct skin application and environmental pressure materially affect outcome.

Label-dose tolerability is generally favourable, but local reactions, transient salivation after licking and rare reversible systemic or neurologic signs can occur. Rabbits must not be treated; age, weight, illness and reproductive-use restrictions apply.

A single monthly Drop-Lock weight-band pipette is straightforward and adds long flea-life-cycle suppression, but the coat must be parted to skin, licking prevented and established household infestation managed environmentally.

All five exact presentations are currently registered in Georgia and the product line retains current UK regulatory records, exact official product information and a favourable fixed-combination assessment.

Regulatory studies and product-specific controlled or field data support adult-flea control, 12-week inhibition of flea development and labelled tick activity. Tick persistence is species-dependent and shorter in cats, while correct skin application and environmental pressure materially affect outcome.

Label-dose tolerability is generally favourable, but local reactions, transient salivation after licking and rare reversible systemic or neurologic signs can occur. Rabbits must not be treated; age, weight, illness and reproductive-use restrictions apply.

A single monthly Drop-Lock weight-band pipette is straightforward and adds long flea-life-cycle suppression, but the coat must be parted to skin, licking prevented and established household infestation managed environmentally.

All five exact presentations are currently registered in Georgia and the product line retains current UK regulatory records, exact official product information and a favourable fixed-combination assessment.

Regulatory studies and product-specific controlled or field data support adult-flea control, 12-week inhibition of flea development and labelled tick activity. Tick persistence is species-dependent and shorter in cats, while correct skin application and environmental pressure materially affect outcome.

Label-dose tolerability is generally favourable, but local reactions, transient salivation after licking and rare reversible systemic or neurologic signs can occur. Rabbits must not be treated; age, weight, illness and reproductive-use restrictions apply.

A single monthly Drop-Lock weight-band pipette is straightforward and adds long flea-life-cycle suppression, but the coat must be parted to skin, licking prevented and established household infestation managed environmentally.

All five exact presentations are currently registered in Georgia and the product line retains current UK regulatory records, exact official product information and a favourable fixed-combination assessment.

Regulatory studies and product-specific controlled or field data support adult-flea control, 12-week inhibition of flea development and labelled tick activity. Tick persistence is species-dependent and shorter in cats, while correct skin application and environmental pressure materially affect outcome.

Label-dose tolerability is generally favourable, but local reactions, transient salivation after licking and rare reversible systemic or neurologic signs can occur. Rabbits must not be treated; age, weight, illness and reproductive-use restrictions apply.

A single monthly Drop-Lock weight-band pipette is straightforward and adds long flea-life-cycle suppression, but the coat must be parted to skin, licking prevented and established household infestation managed environmentally.

Exact strengths have current Georgian registrations and an indefinite Bulgarian authorization with a public product-specific SPC confirming composition, dog-only use and weight bands.

An exact-product report found high activity against several natural infestations, but groups were small, control detail limited and an author was affiliated with the producer. The broad label has moderate, not definitive, clinical support.

A small exact-product study found no measured abnormalities at up to five times the label dose, but cannot exclude uncommon harms. Licking, overdose, reproduction, age or illness, other antiparasitics, ear integrity and environmental exposure need safeguards.

A whole weight-banded pipette simplifies routine dosing. Direct-to-skin placement, prevention of licking, keeping dry and separation until dry add practical burden.

Exact strengths have current Georgian registrations and an indefinite Bulgarian authorization with a public product-specific SPC confirming composition, dog-only use and weight bands.

An exact-product report found high activity against several natural infestations, but groups were small, control detail limited and an author was affiliated with the producer. The broad label has moderate, not definitive, clinical support.

A small exact-product study found no measured abnormalities at up to five times the label dose, but cannot exclude uncommon harms. Licking, overdose, reproduction, age or illness, other antiparasitics, ear integrity and environmental exposure need safeguards.

A whole weight-banded pipette simplifies routine dosing. Direct-to-skin placement, prevention of licking, keeping dry and separation until dry add practical burden.

Exact strengths have current Georgian registrations and an indefinite Bulgarian authorization with a public product-specific SPC confirming composition, dog-only use and weight bands.

An exact-product report found high activity against several natural infestations, but groups were small, control detail limited and an author was affiliated with the producer. The broad label has moderate, not definitive, clinical support.

A small exact-product study found no measured abnormalities at up to five times the label dose, but cannot exclude uncommon harms. Licking, overdose, reproduction, age or illness, other antiparasitics, ear integrity and environmental exposure need safeguards.

A whole weight-banded pipette simplifies routine dosing. Direct-to-skin placement, prevention of licking, keeping dry and separation until dry add practical burden.

Exact strengths have current Georgian registrations and an indefinite Bulgarian authorization with a public product-specific SPC confirming composition, dog-only use and weight bands.

An exact-product report found high activity against several natural infestations, but groups were small, control detail limited and an author was affiliated with the producer. The broad label has moderate, not definitive, clinical support.

A small exact-product study found no measured abnormalities at up to five times the label dose, but cannot exclude uncommon harms. Licking, overdose, reproduction, age or illness, other antiparasitics, ear integrity and environmental exposure need safeguards.

A whole weight-banded pipette simplifies routine dosing. Direct-to-skin placement, prevention of licking, keeping dry and separation until dry add practical burden.

Exact strengths have current Georgian registrations and an indefinite Bulgarian authorization with a public product-specific SPC confirming composition, dog-only use and weight bands.

An exact-product report found high activity against several natural infestations, but groups were small, control detail limited and an author was affiliated with the producer. The broad label has moderate, not definitive, clinical support.

A small exact-product study found no measured abnormalities at up to five times the label dose, but cannot exclude uncommon harms. Licking, overdose, reproduction, age or illness, other antiparasitics, ear integrity and environmental exposure need safeguards.

A whole weight-banded pipette simplifies routine dosing. Direct-to-skin placement, prevention of licking, keeping dry and separation until dry add practical burden.

Exact strengths have current Georgian registrations and an indefinite Bulgarian register entry. Confidence is reduced because the Quadro K page links to the Quadro C dog SPC rather than a K-specific feline SPC; the exact K instruction is available from the manufacturer.

An exact-product report found high activity against several natural infestations, but groups were small, control detail limited and an author was affiliated with the producer. The broad label has moderate, not definitive, clinical support.

A small exact-product study found no measured abnormalities at up to five times the label dose, but cannot exclude uncommon harms. Licking, overdose, reproduction, age or illness, other antiparasitics, ear integrity and environmental exposure need safeguards.

A whole weight-banded pipette simplifies routine dosing. Direct-to-skin placement, prevention of licking, keeping dry and separation until dry add practical burden.

Exact strengths have current Georgian registrations and an indefinite Bulgarian register entry. Confidence is reduced because the Quadro K page links to the Quadro C dog SPC rather than a K-specific feline SPC; the exact K instruction is available from the manufacturer.

An exact-product report found high activity against several natural infestations, but groups were small, control detail limited and an author was affiliated with the producer. The broad label has moderate, not definitive, clinical support.

A small exact-product study found no measured abnormalities at up to five times the label dose, but cannot exclude uncommon harms. Licking, overdose, reproduction, age or illness, other antiparasitics, ear integrity and environmental exposure need safeguards.

A whole weight-banded pipette simplifies routine dosing. Direct-to-skin placement, prevention of licking, keeping dry and separation until dry add practical burden.

The exact presentation is actively registered in Georgia, current official manufacturer instructions verify its composition and labelled use, and an exact-product peer-reviewed field study is available. However, no EMA/FDA-style public assessment, regulator-hosted SPC or transparent full dossier for this formulation was found.

A 2024 exact-product field study reported high efficacy in naturally infested dogs and cats against selected fleas, lice and mites, plus feline Uncinaria, with one-month follow-up. Each parasite group contained only seven animals, the comparator and blinding are inadequately reported, and many broad label targets and prevention claims were not tested.

The small field study reported no adverse effects, but it cannot establish a broad safety margin or detect uncommon events. The label prohibits use in pregnancy, lactation, kittens under 3 months, cats at or below 2 kg, and sick or convalescent animals; licking, overdose and concurrent macrocyclic-lactone exposure remain important concerns.

A whole weight-banded pipette makes routine dosing straightforward, but treatment varies by target: one application, repeated 7-10-day courses for some mites, or monthly heartworm prevention. Correct skin placement, prevention of licking, bathing restrictions, ear examination when relevant and follow-up add meaningful clinical and adherence burden.

The exact presentation is actively registered in Georgia, current official manufacturer instructions verify its composition and labelled use, and an exact-product peer-reviewed field study is available. However, no EMA/FDA-style public assessment, regulator-hosted SPC or transparent full dossier for this formulation was found.

A 2024 exact-product field study reported high efficacy in naturally infested dogs and cats against selected fleas, lice and mites, plus feline Uncinaria, with one-month follow-up. Each parasite group contained only seven animals, the comparator and blinding are inadequately reported, and many broad label targets and prevention claims were not tested.

The small field study reported no adverse effects, but it cannot establish a broad safety margin or detect uncommon events. The label prohibits use in pregnancy, lactation, kittens under 3 months, cats at or below 2 kg, and sick or convalescent animals; licking, overdose and concurrent macrocyclic-lactone exposure remain important concerns.

A whole weight-banded pipette makes routine dosing straightforward, but treatment varies by target: one application, repeated 7-10-day courses for some mites, or monthly heartworm prevention. Correct skin placement, prevention of licking, bathing restrictions, ear examination when relevant and follow-up add meaningful clinical and adherence burden.

The exact presentation is actively registered in Georgia, current official manufacturer instructions verify its composition and labelled use, and an exact-product peer-reviewed field study is available. However, no EMA/FDA-style public assessment, regulator-hosted SPC or transparent full dossier for this formulation was found.

A 2024 exact-product field study reported high efficacy in naturally infested dogs and cats against selected fleas, lice and mites, plus feline Uncinaria, with one-month follow-up. Each parasite group contained only seven animals, the comparator and blinding are inadequately reported, and many broad label targets and prevention claims were not tested.

The small field study reported no adverse effects, but it cannot establish a broad safety margin or detect uncommon events. The label prohibits use in pregnancy, lactation, young, underweight, sick or convalescent animals and specifically warns against use in MDR1-mutant breeds because of possible neurotoxicity.

A whole weight-banded pipette makes routine dosing straightforward, but treatment varies by target: one application, repeated 7-10-day courses for some mites, or monthly heartworm prevention. Correct skin placement, prevention of licking, bathing restrictions, ear examination when relevant and follow-up add meaningful clinical and adherence burden.

The exact presentation is actively registered in Georgia, current official manufacturer instructions verify its composition and labelled use, and an exact-product peer-reviewed field study is available. However, no EMA/FDA-style public assessment, regulator-hosted SPC or transparent full dossier for this formulation was found.

A 2024 exact-product field study reported high efficacy in naturally infested dogs and cats against selected fleas, lice and mites, plus feline Uncinaria, with one-month follow-up. Each parasite group contained only seven animals, the comparator and blinding are inadequately reported, and many broad label targets and prevention claims were not tested.

The small field study reported no adverse effects, but it cannot establish a broad safety margin or detect uncommon events. The label prohibits use in pregnancy, lactation, young, underweight, sick or convalescent animals and specifically warns against use in MDR1-mutant breeds because of possible neurotoxicity.

A whole weight-banded pipette makes routine dosing straightforward, but treatment varies by target: one application, repeated 7-10-day courses for some mites, or monthly heartworm prevention. Correct skin placement, prevention of licking, bathing restrictions, ear examination when relevant and follow-up add meaningful clinical and adherence burden.

The exact 75 cm product has a current time-limited Georgian authorisation, an approved manufacturer instruction and a current Russian register-derived identity record. It has no exact EU/GB/US authorisation or public regulator assessment comparable with current long-acting collar controls.

The three actives have plausible and partly studied ectoparasite activity, and other formulation-specific collars prove multi-month control is possible. However, no public controlled trial of this exact polymer collar, six-month flea/tick/lice claim, five-day dipteran claim or pathogen-transmission endpoints was found; spot-on studies cannot be transferred.

The exact label reports mainly individual erythema/pruritus, but does not provide quantified target-animal safety or continuous-exposure pharmacovigilance. Dog-only cyphenothrin creates potentially severe feline-contact risk; chewing/ingestion, dermatitis, neurologic signs, child contact and aquatic toxicity require explicit controls.

One continuously worn collar can cover the exact label flea/tick/lice period for up to six months and avoids monthly dosing. A 75 cm presentation is easy to fit and trim for a large dog, but correct 1.0-1.5 cm clearance, growth/skin checks, water precautions, household-cat separation and replacement after loss/damage remain necessary.